Media coverage about Core Laboratories (NYSE:CLB) has trended somewhat positive on Wednesday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Core Laboratories earned a daily sentiment score of 0.05 on Accern’s scale. Accern also assigned media coverage about the oil and gas company an impact score of 45.9157589884347 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Core Laboratories (NYSE:CLB) traded down $1.48 on Wednesday, reaching $114.56. 107,874 shares of the company traded hands, compared to its average volume of 380,107. The company has a market capitalization of $5,120.00, a price-to-earnings ratio of 66.67 and a beta of 1.56. Core Laboratories has a one year low of $86.55 and a one year high of $121.39. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.81 and a current ratio of 2.18.
The company also recently declared a quarterly dividend, which will be paid on Friday, February 16th. Stockholders of record on Friday, January 26th will be issued a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.92%. The ex-dividend date of this dividend is Thursday, January 25th. Core Laboratories’s payout ratio is 127.17%.
A number of analysts have recently issued reports on CLB shares. Cowen set a $100.00 target price on shares of Core Laboratories and gave the stock a “hold” rating in a research note on Friday, October 6th. Deutsche Bank assumed coverage on shares of Core Laboratories in a research note on Tuesday, October 10th. They issued a “buy” rating and a $109.00 price objective for the company. Zacks Investment Research raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Royal Bank of Canada reissued a “buy” rating on shares of Core Laboratories in a report on Wednesday, October 18th. Finally, Piper Jaffray Companies set a $97.00 target price on shares of Core Laboratories and gave the stock a “hold” rating in a report on Monday, October 23rd. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the stock. Core Laboratories currently has a consensus rating of “Hold” and an average target price of $111.70.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/31/core-laboratories-clb-earning-somewhat-favorable-press-coverage-study-shows.html.
About Core Laboratories
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.